See more : Ulisse Biomed S.p.A. (UBM.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Sunac China Holdings Limited (1918.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sunac China Holdings Limited, a leading company in the Real Estate – Development industry within the Real Estate sector.
- ENCE Energía y Celulosa, S.A. (ENC.MC) Income Statement Analysis – Financial Results
- Photocure ASA (PHCUF) Income Statement Analysis – Financial Results
- Purple Group Limited (PPE.JO) Income Statement Analysis – Financial Results
- Taiwan Paiho Limited (9938.TW) Income Statement Analysis – Financial Results
- IncentiaPay Limited (INP.AX) Income Statement Analysis – Financial Results
Sunac China Holdings Limited (1918.HK)
About Sunac China Holdings Limited
Sunac China Holdings Limited, together with its subsidiaries, invests in, develops, and sells residential and commercial properties in the People's Republic of China. The company provides conferences and exhibitions, tourism and vacations, theme parks, hotel operations, medical and health care, IP development and operation, and film and television content production and distribution services. It is also involved in property services, commercial operations, property management, fitting and decoration, and cultural and tourism city construction and operation activities. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 154.23B | 96.75B | 198.39B | 230.59B | 169.32B | 124.75B | 65.87B | 35.34B | 23.01B | 25.07B | 30.84B | 20.84B | 10.60B | 6.65B | 4.80B |
| Cost of Revenue | 156.73B | 100.65B | 211.20B | 182.18B | 127.91B | 93.61B | 45.07B | 29.08B | 20.11B | 20.20B | 23.56B | 15.46B | 7.04B | 3.78B | 3.44B |
| Gross Profit | -2.50B | -3.90B | -12.81B | 48.40B | 41.41B | 31.14B | 20.80B | 6.27B | 2.90B | 4.88B | 7.28B | 5.38B | 3.57B | 2.88B | 1.36B |
| Gross Profit Ratio | -1.62% | -4.03% | -6.46% | 20.99% | 24.46% | 24.96% | 31.57% | 17.73% | 12.61% | 19.45% | 23.61% | 25.82% | 33.63% | 43.26% | 28.34% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.49B | 6.98B | 8.43B | 8.47B | 8.29B | 7.36B | 3.54B | 1.34B | 775.02M | 680.74M | 520.14M | 354.54M | 301.08M | 155.82M | 113.62M |
| Selling & Marketing | 4.87B | 5.79B | 8.77B | 8.04B | 6.17B | 4.36B | 3.42B | 916.23M | 661.05M | 697.30M | 615.45M | 529.96M | 314.09M | 108.80M | 67.96M |
| SG&A | 10.37B | 15.24B | 24.07B | 16.91B | 16.19B | 14.96B | 8.98B | 2.26B | 1.44B | 1.38B | 1.14B | 884.50M | 615.17M | 264.62M | 181.58M |
| Other Expenses | -10.93B | 1.13B | 888.14M | 1.72B | 2.33B | 1.09B | 552.10M | 295.25M | 65.27M | 2.70M | 0.00 | 3.77M | -846.21M | 129.27M | 188.06M |
| Operating Expenses | -568.76M | 25.08B | 33.98B | 4.32B | 1.27B | 5.12B | 3.55B | 1.27B | 2.22B | 187.34M | 1.06B | 874.11M | -231.04M | 223.54M | 148.60M |
| Cost & Expenses | 156.16B | 125.73B | 245.18B | 186.50B | 129.18B | 98.73B | 48.62B | 30.35B | 22.33B | 20.38B | 24.61B | 16.33B | 6.81B | 4.00B | 3.58B |
| Interest Income | 1.76B | 2.33B | 3.12B | 4.61B | 2.09B | 2.05B | 2.57B | 888.27M | 556.56M | 160.94M | 537.71M | 29.17M | 18.69M | 18.50M | 0.00 |
| Interest Expense | 4.95B | 5.94B | 2.10B | 1.16B | 3.93B | 1.69B | 5.34B | 2.15B | 1.68B | 1.26B | 612.24M | 99.90M | 202.03M | 186.76M | 113.26M |
| Depreciation & Amortization | 3.58B | 3.19B | 3.78B | 2.73B | 1.82B | 992.16M | 339.15M | 35.11M | 27.94M | 24.68M | 23.97M | 14.89M | 52.33M | 10.27M | 10.68M |
| EBITDA | 3.40B | -14.99B | -37.79B | 34.54B | 28.81B | 18.10B | 11.80B | 4.44B | 1.69B | 3.54B | 6.23B | 4.80B | 3.78B | 2.79B | 1.47B |
| EBITDA Ratio | 2.20% | -15.49% | -18.15% | 14.98% | 17.02% | 14.51% | 17.91% | 12.57% | 7.33% | 14.13% | 20.20% | 21.70% | 35.67% | 41.99% | 30.57% |
| Operating Income | -1.93B | -18.11B | -39.13B | 32.52B | 27.53B | 17.10B | 11.49B | 4.41B | 1.66B | 3.52B | 6.21B | 4.69B | 3.72B | 2.65B | 1.27B |
| Operating Income Ratio | -1.25% | -18.72% | -19.73% | 14.10% | 16.26% | 13.71% | 17.44% | 12.47% | 7.21% | 14.03% | 20.12% | 22.49% | 35.10% | 39.90% | 26.42% |
| Total Other Income/Expenses | -3.20B | -9.27B | 2.43B | 24.81B | 14.69B | 10.97B | 3.19B | -1.44B | 2.91B | 1.38B | -433.52M | -2.76M | -193.32M | -38.98M | 74.80M |
| Income Before Tax | -5.13B | -31.30B | -43.67B | 57.33B | 42.23B | 28.07B | 14.68B | 4.11B | 4.56B | 4.90B | 5.68B | 4.68B | 3.53B | 2.60B | 1.34B |
| Income Before Tax Ratio | -3.33% | -32.35% | -22.01% | 24.86% | 24.94% | 22.50% | 22.28% | 11.62% | 19.83% | 19.55% | 18.43% | 22.48% | 33.27% | 39.03% | 27.98% |
| Income Tax Expense | 5.28B | 1.41B | 1.67B | 17.99B | 14.39B | 11.22B | 3.69B | 1.47B | 955.31M | 1.67B | 2.19B | 2.07B | 1.15B | 1.06B | 470.84M |
| Net Income | -7.97B | -27.67B | -38.26B | 35.85B | 26.35B | 17.16B | 11.68B | 2.78B | 3.30B | 3.22B | 3.18B | 2.61B | 2.36B | 1.54B | 825.06M |
| Net Income Ratio | -5.17% | -28.60% | -19.29% | 15.55% | 15.56% | 13.75% | 17.74% | 7.87% | 14.33% | 12.85% | 10.31% | 12.51% | 22.22% | 23.18% | 17.21% |
| EPS | -1.43 | -5.16 | -8.27 | 7.82 | 5.99 | 3.92 | 2.76 | 0.71 | 0.97 | 0.96 | 0.95 | 0.87 | 0.79 | 0.64 | 0.28 |
| EPS Diluted | -1.43 | -5.16 | -8.27 | 7.74 | 5.92 | 3.87 | 2.70 | 0.71 | 0.96 | 0.95 | 0.95 | 0.86 | 0.78 | 0.64 | 0.28 |
| Weighted Avg Shares Out | 5.57B | 5.36B | 4.63B | 4.56B | 4.35B | 4.38B | 3.99B | 3.47B | 3.39B | 3.35B | 3.35B | 3.00B | 3.00B | 2.42B | 3.00B |
| Weighted Avg Shares Out (Dil) | 5.58B | 5.36B | 4.63B | 4.60B | 4.40B | 4.43B | 4.07B | 3.49B | 3.43B | 3.38B | 3.36B | 3.04B | 3.00B | 2.43B | 3.00B |
Source: https://incomestatements.info
Category: Stock Reports